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Letters to the Editornodes and masses, puncturing the me-
dial and lateral wall of the aorta; the
risk of this maneuver was high, how-
ever, and the procedure did not gain
wide clinical application.
In this article, Liberman and col-
leagues1 presented the results of biop-
sies of station 6 lymph nodes
performed without traversing the
aorta: the needle is passed through
the esophageal wall and introduced
for 6 to 8 cm toward the para-aortic lo-
cation, avoiding the aorta and great
vessels to reach the nodes that are
not visualized when passing the nee-
dle into the mediastinum (see the orig-
inal article for details).
Liberman and colleagues1 must be
congratulated for their skill, dexterity,
and boldness in ideating and realizing
this procedure. The results are very
persuasive, with reported 100% suc-
cess in reaching and obtaining cyto-
logic material from the station 6
lymph node with no complications in
21 patients.
We believe, however, that it is appro-
priate to say a fewwords of caution and
to direct the reader’s attention to two
points. First, the procedure appears
very complicated and dangerous, and
the excellent results reported by Liber-
man and colleagues1 are probably due
to a high volume of endoscopic and en-
dobronchial ultrasonographic activity
at their center. We must also consider
that the indications are very rare (12
cases performed out of 274 combined
endobronchial and endoscopic ultraso-
nographic procedures at their center1),
and the learning curve in a medium-
activity center could be very long.
Second, are these results widely repro-
ducible? Biopsy of station 6 lymph no-
des can also be obtained by single-port
video-assisted thoracoscopy. In that
case, the specimen is wider (it can un-
dergo all histologic and immunohisto-
chemical studies required), and the
procedure is technically easier and
can be performed by every thoracic sur-
geon with a 1- or 2-day hospital stays.
Moreover, the risks (both for the pa-
tient’s great vessels and for the888 The Journal of Thoracic and Csurgeon’s own coronary arteries) asso-
ciated with passing a needle out in the
mediastinum close to great vessels
without direct control but only amental
image is avoided.
We conclude by congratulating
Libermanandcolleagues1 for theproce-
dure proposed and the results reported.
We have some doubts, however, about
the reproducibility of their technique
and its true advantage relative to easier
and safer ways to reach para-aortic
lymph nodes, such as a single-port
video-assisted thoracoscopy.
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I thank Baisi and colleagues for
their comments regarding our tech-
nique for the biopsy of station 6 lymph
nodes by using endoscopic ultrasound
without traversing the aorta. I would
like to respond to the points they
brought forward.
First, their point is well taken re-
garding the complexity of the proce-
dure and the difficulty in reproducing
these results in lower-volume centers.
Such a concern, however, is not spe-
cific to this procedure, as it is well es-
tablished that high-volume centers
typically have superior outcomes to
lower-volume centers, especially
when it comes to complex procedures.
Furthermore, multiple fellows, visit-
ing surgeons, and trainees in our
center have been trained in this proce-
dure and are currently using it in their
present places of work around the
world. I would add that there are
many complex procedures that can be
construed to be ‘‘dangerous’’ (such as
minimally invasive esophagectomy,
carinal resection, and lung transplanta-
tion) are being performed by thoracic
surgeons around the world. In fact,
putting a 22-gauge needle through
the esophagus to pierce a lymph node
that sits on the lateral arch of the aorta
is far less ‘‘dangerous’’ thanmany pro-
cedures that we perform on a daily
basis.
Second, although I agree that bi-
opsy of station 6 lymph nodes can be
obtained by single-port thoracoscopy
(or anterior mediastinoscopy), I dis-
agree with the point that these are
equivalent procedures to that de-
scribed in the article. Although these
procedures are safe and simple, the
endoscopic ultrasound technique de-
scribed is performed as an outpatient
procedure and can be done under local
anesthesia and sedation in an endos-
copy suite, therefore avoiding general
anesthesia, an operating room, and
any hospitalization whatsoever. In to-
day’s climate of cost-effectiveness in
medicine, I believe that a 20- to 30-
minute outpatient procedure is far
Letters to the Editorsuperior to an operation requiring
a 2-day hospitalization from a socio-
economic standpoint.
Another advantage to this tech-
nique is that it can be performed as
part of a complete echo-endoscopic
mediastinal staging procedure (endo-
bronchial ultrasoundþ endoscopic ul-
trasound), which can now allow for
the evaluation and biopsy of all medi-
astinal lymph node stations during
a single outpatient endoscopic proce-
dure. Single-port thoracoscopy cannot
provide complete mediastinal staging,
therefore necessitating additional pro-
cedures in cases requiring it.
Moishe Liberman, MD, PhD
CHUM Endoscopic Tracheobronchial
and Oesophageal Center
Division of Thoracic Surgery
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j.jtcvs.2012.12.019CARDIAC CYCLE EFFICIENCY
DURING COUNTERPULSATION
To the Editor:
We readwith great interest the recent
article by Onorati and colleagues,1
whose findings are in accordance with
our own data obtained in an animal
model arranged to investigate the ef-
fects of intra-aortic balloon pump
(IABP)/heart volume ratio modifica-
tion.2 We congratulate them for having
addressed such a controversial topic
and for shedding additional light on
the IABP weaning method. Indeed,
this publication underlines the superi-
ority of progressive volume variation
relative to the traditional rate reduction
method as a procedure for IABP wean-
ing, as we hypothesized on the basis of
the negative effects of reducing the
IABP/heart volume ratio, in terms of
both hemodynamic performance and
metabolic response.
Onorati andcolleagues1 used the car-
diac cycle efficiency (CCE), derivedThe Journalfrom the arterial pressure waveform,
as their measure of hemodynamic per-
formance. The CCE expresses the abil-
ity of the cardiovascular system to
maintain homeostasis at different en-
ergetic levels resulting from simulta-
neous interactions among pump
function (both mechanical and electri-
cal contributions), the arterial system,
venous return, and the pulmonary
circulation.3
We noticed, however, that patients
in both groups had high CCEs. The
value of the CCE is always less than
1, because part of energy is lost during
heart work and cannot be totally re-
covered (an increase in entropy).
This ‘‘efficiency’’—unlike the purely
mechanical performance, which is al-
ways between 0 and 1—can also ha-
ve in vivo negative values, and
this represents a compensatory mech-
anism to activate the support for the
body’s compartments that are not
working properly.3
Such high CCE values in the article
of Onorati and colleagues1 might be
attributable to underdamping or reso-
nance artifacts that frequently affect
blood pressure measurements in oper-
ating rooms and intensive care units
and cause severe overestimation of
systolic blood pressure and incorrect
estimation of hemodynamic parame-
ters when the pulse contour method
is used.4 It is well known that patients
undergoing cardiovascular surgery are
at high risk of artifacts caused by
underdamping because of high vascu-
lar stiffness, advanced age, and other
conditions.4 In addition, the dynamic
impedance is strongly influenced by
the balloon in patients with IABPs,
and as a result artifacts are very com-
mon, affecting the diastolic peak. In
our opinion, great attention must
therefore be paid to the accuracy of
the pressure signals received during
IABP weaning procedures.
It is also important to consider that
the damping coefficients of standard
transducer systems have been manu-
factured with the aim of obtaining
the highest level of detail availableof Thoracic and Cardiovascular Surgefrom the arterial wave signal while
maintaining the risk of underdamping
as low as possible for the whole
patient population, and not a specific
group of patients. Extra damping
must therefore be introduced to mini-
mize the distorting effects of the
measurement system’s tendency to
resonate. Nonetheless, the damping
coefficient obtained is frequently in-
sufficient, and resonance artifacts
may affect the morphology and am-
plitude of the recorded pressure
wave. Under these conditions, a dedi-
cated transducer manufactured for
limiting resonant effect is an useful
device, although interpretation of
the resulting waveform does require
some experience.5
We would appreciate comments
from Onorati and colleagues1 regard-
ing whether this issue was addressed
and how they proceeded to limit these
underdamping artifacts.
We are grateful to Onorati and col-
leagues1 for sharing their experience
and knowledge in this excellent study.
An elucidation and comment of the
point discussed here would be helpful
for a better understanding of the nu-
ances of IABP pathophysiology and
management in these patients.
Sandro Gelsomino, MD, PhD
Salvatore Mario Romano, PhD
Department of Heart and Vessels
Careggi Hospital
Florence, Italy
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